- Home
- CMND vs FGNX Comparison
CMND vs FGNX Comparison
Compare CMND & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMND | FGNX |
|---|---|---|
| Founded | 2017 | 1932 |
| Country | Canada | United States |
| Employees | N/A | 130 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 47.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMND | FGNX |
|---|---|---|
| Price | $1.00 | $6.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | 54.6K | ★ 137.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $95.83 |
| Revenue Next Year | N/A | $42.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $1.59 |
| 52 Week High | $3.25 | $18.42 |
Technical Indicators
Market Signals| Indicator | CMND | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 31.81 | 58.79 |
| Support Level | $0.98 | $5.43 |
| Resistance Level | $1.07 | $9.35 |
| Average True Range (ATR) | 0.09 | 0.51 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 9.94 | 18.25 |
Price Performance
Historical ComparisonAbout CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
About FGNX Fundamental Global Inc.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.